PFAS Legal Challenges: Navigating the Complex Landscape of Regulation, Litigation, and Innovation

Introduction

As the awareness of per- and polyfluoroalkyl substances (PFAS) escalates, so too do the legal challenges surrounding their presence in the environment and human health. Responsible for manufacturing innovative household and industrial products, PFAS have become a double-edged sword—offering utility while posing substantial environmental concerns. By July 2025, the legal landscape surrounding PFAS has evolved into a labyrinth of regulatory initiatives, litigation battles, and compensation claims, reflecting the urgent necessity for municipalities, industries, and affected communities to adapt. Understanding these legal challenges not only speaks to accountability but also highlights the approaches organizations can take to manage risks effectively.

Legal exposure is the dimension of PFAS Wastewater Treatment that arrives independently of any treatment decision. A utility can be fully compliant with every applicable standard and still face cost recovery claims, permit conditions it did not anticipate, and notification duties triggered by data it collected voluntarily. The sections below separate the instruments involved, because they attach to different parties, arise from different statutes, and respond to entirely different mitigation strategies.

This page is general information for water and wastewater professionals, not legal advice. Positions in this area are moving quickly and vary by jurisdiction; obtain advice from counsel qualified in your state before acting on any of it.

Understanding PFAS and Their Implications

What Are PFAS?

PFAS are a group of over 5,000 synthetic chemicals known for their ability to repel water and oil. Used extensively across numerous applications—from non-stick cookware to firefighting foam—PFAS have gained notoriety as "forever chemicals" due to their persistence in the environment and human body.

Health and Environmental Concerns

Recent studies have associated PFAS with various health issues, including:

• Hormonal Disruption: According to the Centers for Disease Control and Prevention (CDC), some PFAS have been linked to thyroid disease and certain cancers.
• Reproductive Harm: Research published in Environmental Health Perspectives indicates potential risks to fetal development, including low birth weight and preterm birth.
• Bioaccumulation: PFAS bioaccumulate over time, leading to elevated concentrations in both water supplies and human organisms.

The urgency to tackle these chemicals is reinforced by their widespread detection in drinking water across the United States, with the Environmental Protection Agency (EPA) noting that an estimated 200 million Americans could be exposed to contaminated water.

PFAS Legal Challenges: An Expanding Landscape

Historical Context and Regulatory Framework

The journey to comprehending PFAS legal challenges began in earnest in the early 2000s. Initially, lawsuits were often localized, focusing on industrial sites and military installations. However, as awareness expanded, so too did the scope of litigation, drawing in municipalities, manufacturers, and even consumers.

Key Regulatory Developments

1. EPA’s PFAS Action Plan: As of 2024, the EPA has instituted a multi-faceted action plan to address PFAS through:

   • Drinking Water Standards: Proposed maximum contaminant levels for two specific PFAS (PFOA and PFOS) update the standards first put into place in 2016.
   • Monitoring Requirements: New mandates require public water systems to regularly test for PFAS and report findings, enhancing transparency for communities.

2. State-Level Regulations: Several states have taken proactive legal measures amidst federal inaction, with California and Michigan leading the way in setting stringent guidelines and limits.

3. International Initiatives: The European Union’s REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) regulations may influence global standards, pressing manufacturers to reconsider PFAS production.

Types of Legal Battles

Litigation against Manufacturers

Lawsuits are increasingly filed against chemical manufacturers and corporations for contaminating public water supplies. Notably, in 2024, a landmark case led to a $1 billion settlement beneficial to affected communities in Ohio. Many states have started legal proceedings, frequently citing negligence, public nuisance, and failure to warn.

Municipal Liability

Local governments are grappling with the financial burden of PFAS remediation. Lawsuits driven by community health outcomes are leading to significant settlements. Municipalities are searching for recovery funds, sometimes targeting manufacturers or seeking reimbursements from state or federal governments.

Class Action Lawsuits

Many of the affected individuals and communities are pursuing class action lawsuits. These suits leverage the high volume of claims associated with shared experiences of PFAS exposure, focusing on damages linked to medical conditions and environmental degradation. For example, a class action in New Mexico has highlighted how PFAS exposure has led to widespread contamination across multiple water utilities.

Technological Innovations as Solutions

Remediation Innovations

Emerging technologies in water treatment are playing a pivotal role in addressing PFAS contamination. Innovative solutions include:

Advanced Oxidation Processes (AOPs)

Studies indicate that combining ozone and ultraviolet (UV) light effectively degrade PFAS biologically and chemically, offering municipalities a promising avenue for remediation without resorting to costly alternatives.

Granular Activated Carbon (GAC)

Although GAC has been widely employed for PFAS removal, advancements in its regeneration methods have reduced lifetime operational costs, making it a more viable option for long-term water treatment.

How Organizations Can Prepare

Compliance Strategies

Staying informed about evolving regulations is key. Organizations should invest in:

• Regular Monitoring and Testing: Diligent compliance with testing requirements helps reduce liabilities and equips organizations to respond proactively to contamination incidents.
• Legal Oversight: Engaging legal experts specializing in environmental law can aid in understanding the nuances of PFAS litigation and compliance.

Risk Management and Public Relations

Proactively addressing community concerns fosters trust. Transparent communication, along with engagement with local stakeholders, can mitigate backlash and contribute to more effective risk management strategies.

The Federal Legal Instruments

Three federal instruments generate most of the current legal exposure, and they operate quite differently from one another. Each is treated in depth on its own page.

CERCLA Hazardous Substance Designation

The single most consequential legal development in this area is one the discussion above does not reach: in 2024 the EPA designated PFOA and PFOS as hazardous substances under the Comprehensive Environmental Response, Compensation, and Liability Act. Our dedicated coverage of the PFAS hazardous substance designation works through what that actually changes — release reporting obligations above the reportable quantity, exposure to cost recovery and contribution actions, the consequences for property transactions and due diligence, and the enforcement discretion policy the agency published alongside it indicating which parties it does not intend to pursue. That policy is not a legal shield: it constrains the EPA’s own enforcement, not private cost recovery claims between parties, which is where most utilities will actually encounter CERCLA liability.

Clean Water Act Discharge Permitting

For any facility holding a discharge permit, obligations arrive through that permit rather than through a national standard. Our coverage of NPDES permit PFAS requirements addresses how monitoring conditions are being written into permits at renewal, the pretreatment programme obligations that apply to publicly owned treatment works receiving industrial contributions, effluent limitations where a state has adopted them, and the sequence a permittee follows when a permit writer proposes a PFAS condition. Because permits are negotiated individually and renewed on a cycle, this is the instrument most amenable to being shaped in advance rather than responded to.

Public Notification Duties

Detection triggers communication obligations independent of whether a limit is exceeded, and these duties carry their own legal exposure when they are discharged late or badly. Our page on PFAS public notification requirements covers Consumer Confidence Report content, the notification timelines and prescribed language that follow an exceedance, the tier structure that determines urgency, and the state variations that frequently exceed federal requirements. Failure to notify is a violation in its own right, separate from the underlying exceedance, and it is the failure most likely to generate reputational and political consequences disproportionate to its regulatory weight.

The Drinking Water Standard Itself

Underlying all three is the National Primary Drinking Water Regulation for PFAS, finalised in April 2024. It established enforceable maximum contaminant levels of 4.0 nanograms per litre for PFOA and for PFOS, 10 nanograms per litre for PFHxS, PFNA and HFPO-DA, and a Hazard Index approach for mixtures. These are promulgated, enforceable standards — distinct in legal character from the 2016 and 2022 health advisories, which were non-binding guidance values and never functioned as standards. Elements of the 2024 rule, including the compliance schedule and the treatment of the compounds beyond PFOA and PFOS, have been subject to subsequent agency reconsideration and litigation, so the operative requirement and date should be confirmed against the current Federal Register text and the state primacy agency before any decision is taken.

The Litigation Landscape

The Aqueous Film-Forming Foam Multidistrict Litigation

The centre of gravity in US PFAS litigation is the AFFF multidistrict litigation consolidated in the District of South Carolina, which has aggregated thousands of cases brought by water providers, states, and personal injury claimants. Two water-provider settlements emerged from it: a 3M settlement with a headline value in the billions, structured as phased payments to public water systems that detected PFAS, and a smaller settlement with DuPont, Chemours, and Corteva. Both operate on a claims process with participation deadlines and opt-out decisions that carry consequences for any future claim. Any utility that has detected PFAS should establish where it sits relative to those processes, because the deadlines are firm and passive non-participation is itself a decision.

State Attorney General Actions

A growing number of state attorneys general have brought natural resource damage and public nuisance actions against manufacturers, several of which have settled for substantial sums earmarked for remediation and water system upgrades. These are separate from the MDL and from individual utility claims. For a utility, the practical relevance is that state settlement proceeds sometimes fund treatment in ways that grant programmes do not, and eligibility is worth checking with the state agency.

Personal Injury and Medical Monitoring

Individual claims alleging disease causation proceed on a different evidentiary footing from water-provider claims, requiring proof of exposure and of specific causation. Medical monitoring claims — seeking funded surveillance rather than damages for present injury — are recognised in some states and not others, which is a significant driver of where litigation is filed. Utilities are more often witnesses or third parties in these actions than defendants, but discovery obligations can still be substantial.

Statutes of Limitation and the Discovery Problem

PFAS claims raise an unusually difficult timing question. Limitation periods generally run from when a claimant knew or should have known of an injury, and with contamination that was undetectable by routine analysis until recently, and unregulated until 2024, the question of when a utility “should have known” is genuinely contested. Several states have legislated to clarify or extend the position specifically for PFAS. The practical consequence is that a system which detected PFAS years ago and took no action may be in a different position from one detecting it for the first time now — and that a decision to defer a claim can foreclose it. Where a system has historic detection data, establishing the limitation position early is more urgent than it appears.

Where Utilities Sit

Public water systems occupy an unusual position: predominantly plaintiffs seeking cost recovery, occasionally defendants where notification or treatment decisions are challenged, and frequently custodians of the monitoring data on which other parties’ cases depend. That third role is the one most often underestimated, and it is why data quality and documentation practice in this area have legal consequences well beyond compliance.

State Law Is Moving Faster Than Federal

The most common planning error in this area is tracking federal developments and treating state action as secondary. The reverse is closer to the truth. States have set drinking water standards more stringent than the federal values, established their own cleanup and screening levels for soil and groundwater where no federal standard exists at all, restricted or prohibited biosolids land application on PFAS grounds, banned PFAS in specific product categories, and imposed reporting duties on manufacturers selling into the state. Several have also extended or clarified statutes of limitation in ways that materially affect claim viability.

For a multi-jurisdiction operator this produces genuinely different obligations across otherwise identical facilities, and for a single-state operator it means the state agency is the primary authority rather than a secondary one. Comparison tables maintained by trade associations and law firms are a reasonable starting point for orientation, but they age quickly and should be verified against the primary state source before anything is relied on. Set a fixed review cadence for your state’s rulemaking calendar rather than waiting to be notified.

The Insurance and Indemnity Position

Coverage is worth examining separately from liability, because it is changing independently. Insurers have introduced PFAS-specific exclusions into new and renewing policies, which means historic policies may respond where current ones do not — making the archive of expired policies a potentially valuable asset rather than a filing burden. Disputes over whether historic general liability and pollution policies cover PFAS claims are themselves an active area of litigation with outcomes varying by jurisdiction and policy wording. Separately, indemnity provisions in construction contracts, equipment supply agreements, biosolids hauling contracts, and property transfers allocate PFAS risk between parties in ways that are frequently overlooked at signature and decisive afterwards. Both deserve review by someone who reads policies and contracts for a living.

Exposure by Party Type

Legal exposure differs sharply by what kind of organisation you are. The table below sets out the principal instruments and where each party’s risk actually concentrates.

What a Legal Position Rests On

Whatever posture an organisation ends up in — claimant, defendant, permittee, or witness — the same small set of things determines how strong that position is. Knowing when contamination was first detected and being able to evidence it. Being able to show what the applicable requirement was on the date a decision was taken, which in a period of active reconsideration is not always obvious in retrospect. Having monitoring data that meets an evidentiary rather than merely a compliance standard. Having documented the alternatives considered and the reasons for the choice made. And having met notification duties on time and in the prescribed form.

None of that is legal strategy; it is record-keeping discipline that happens to have legal consequences. It also costs almost nothing to maintain prospectively and is impossible to create retrospectively, which is the argument for putting it in place before it is needed rather than when a claim or a request for information arrives.

Practical Guidance

Document the Basis of Every Decision, With Dates

In an area where requirements are actively contested, the difference between a defensible position and an indefensible one is frequently the record. Keep dated documentation of what was known when, what position was taken, what advice informed it, and what the applicable requirement was at that time. A utility that can show it acted deliberately on the information available is in a materially different position from one reconstructing its reasoning afterwards.

Treat Monitoring Data as Potential Evidence

Data collected for compliance frequently ends up serving a legal purpose, and the evidentiary standard is higher than the compliance standard. Chain of custody, accredited laboratories, documented field protocol, and full quality control packages are what make a dataset usable in cost recovery or defence. The analytical practices that support this are covered in our discussion of PFAS monitoring and analysis. Retain analyte-level results rather than summed values, and retain them for longer than the minimum regulatory period.

Track Claim Deadlines Actively

Settlement participation windows, opt-out dates, and filing deadlines arrive on schedules set by courts and administrators rather than by your operational calendar, and missing one can forfeit a claim entirely. Assign responsibility for tracking them to a named person. Passive non-participation in a class settlement is a decision with consequences, and it should be a deliberate one taken on advice.

Build Compliance and Legal Strategy Together

Compliance decisions have legal consequences and vice versa: a treatment choice affects residual liability, a notification decision affects reputational and legal exposure, and a permit negotiation shapes obligations for years. Running these as separate workstreams produces avoidable conflicts. The programme structures that keep them aligned are set out in our coverage of PFAS program management.

Understand the Health Evidence You Are Relying On

Causation arguments, risk communication, and the defensibility of any position on exposure all rest on the toxicological evidence base, and that base is stronger for some compounds and endpoints than others. Our coverage of PFAS health and safety sets out what the evidence supports and where it remains contested — a distinction worth understanding before making public statements that may later be examined.

Resources and References

Primary Sources

• Federal Register — the only authoritative record of what is proposed, final, stayed, or reconsidered.
• Your state primacy agency and state environmental agency — the operative authority for most obligations, and frequently more stringent than federal requirements.
• Court dockets for the AFFF MDL and any relevant state action — settlement administrators publish participation deadlines and claim procedures.
• EPA PFAS enforcement discretion policy — read it for what it does not cover, which is private cost recovery.

Professional Support

• Environmental counsel qualified in your state — PFAS liability is highly jurisdiction-specific and moving quickly.
• State water and rural water associations — frequently circulate settlement guidance and coordinate collective responses for small systems.
• AWWA and WEF — rulemaking tracking, comment coordination, and member briefings.
• Your insurer and broker — pollution liability coverage terms and PFAS exclusions have been changing, and existing policies are worth reviewing specifically.

Frequently Asked Questions

Does the CERCLA designation make utilities liable for PFAS they did not create?

Potentially, which is why it matters. CERCLA liability attaches broadly and is not limited to the party that manufactured or first released a substance; parties that arranged for disposal or transported material can be drawn in. The EPA published an enforcement discretion policy indicating it does not intend to pursue certain parties including public water systems and publicly owned treatment works acting in that capacity. That policy binds the agency’s own enforcement; it does not prevent private parties from bringing cost recovery or contribution claims. The distinction is important and is frequently misunderstood.

Is the drinking water rule a proposal or a final standard?

Final. The National Primary Drinking Water Regulation for PFAS was proposed in March 2023 and finalised in April 2024, establishing enforceable maximum contaminant levels. Earlier values — the 2016 and 2022 health advisories — were non-binding guidance and never functioned as standards, which is a distinction that matters legally. Elements of the 2024 rule have since been subject to agency reconsideration and litigation, so confirm the operative schedule with your state primacy agency.

Should a utility join a PFAS settlement?

That is a decision for counsel on the specific facts, but the timing question is universal: participation windows and opt-out deadlines are firm, and letting one pass without a decision forfeits options. Understand where your system sits relative to any active process, what participation would require in documentation, and what opting out preserves or gives up. Many state associations have circulated guidance for small systems that cannot fund individual analysis.

What legal exposure comes from public notification?

Failure to notify is a violation independent of the underlying exceedance, with its own timelines and prescribed content. Beyond formal violation, notification handled late or in language that is later shown to have understated a known result creates exposure that is difficult to manage. The practical protection is preparing notification material before results arrive, when there is time to get the language right and no incentive to shade it.

How does PFAS affect property transactions?

The CERCLA designation brought PFAS squarely into environmental due diligence. Pre-acquisition assessment now routinely considers PFAS where site history suggests use — firefighting training, metal finishing, textile or paper coating, landfilling — and the protections available to a purchaser depend on having conducted appropriate inquiry before acquiring. Acquiring without that inquiry can forfeit defences that would otherwise be available.

Does insurance cover PFAS liability?

Increasingly less, and it depends heavily on policy vintage and wording. Insurers have been introducing PFAS-specific exclusions, and coverage disputes over historic policies are themselves an active area of litigation. Any organisation with potential exposure should review current and historic policies with a broker or coverage counsel rather than assuming pollution liability cover responds.

How long should PFAS records be retained?

Longer than the minimum compliance period, and the reason is evidentiary rather than regulatory. Cost recovery claims, contribution actions, and coverage disputes can turn on what a party knew and when, and on the analytical record supporting a concentration at a point in time. Records worth retaining indefinitely include analyte-level monitoring results with their quality control packages, chain-of-custody documentation, correspondence with regulators, the dated basis for significant decisions, historic insurance policies, and contracts containing indemnity or environmental provisions. Storage is inexpensive relative to the cost of being unable to evidence a position years later.

Does a utility need PFAS-specific legal support, or will general counsel suffice?

It depends on posture. Routine compliance questions — monitoring schedules, notification content, permit conditions — are generally within the competence of counsel already advising the utility, provided they are tracking the area. Cost recovery participation, settlement opt-out decisions, CERCLA exposure assessment, and coverage disputes are specialist territory where the relevant experience is both technical and jurisdiction-specific. Many state associations have arranged group access to specialist advice for smaller systems that cannot retain it individually, which is worth asking about before assuming the cost is prohibitive.

Conclusion

The landscape of PFAS legal challenges in 2025 illustrates a convergence of public health concerns, regulatory obligations, and legal accountability. As municipalities, industries, and communities grapple with the repercussions of past PFAS usage, understanding the intricacies of this issue—coupled with an eye on innovative solutions—will be vital. By aligning remediation technologies with robust legal compliance strategies, organizations can navigate the complexities of PFAS challenges while safeguarding the health of their communities and the environment.

By maintaining vigilance and creating informed plans of action, stakeholders can not only meet current legal obligations but also position themselves toward a sustainable, PFAS-free future.